Russ Belden is the President & CEO of Life Sciences Bridge Consulting LLC, which specializes in capturing the intrinsic value of client assets through the seamless integration of strategic marketing and commercial planning expertise to support life cycle management, create differentiated products and enhance value. Over the past eight years, “ Bridge” has worked with over 25 emerging stage biotech companies and was recognized by the Biotechnology Industry Organization (BIO) for their commercial expertise. Prior to Bridge Consulting, Russ spent 16 years at Genentech, including 7 years in marketing and launching the BioOncology business through the Rituxan and Herceptin launches. Russ earned a B.S. in Pharmacy from the University of Buffalo and completed 2/3 of a Masters in Marketing program at the University of Texas at Dallas prior to Genentech relocation to bay area.